Phenotypic variants of autoimmune peripheral nerve hyperexcitability.
about
The emerging diversity of neuromuscular junction disordersAnti-Ri antibodies associated with short-term memory deficits and a mature cystic teratoma of the ovaryPotassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitisKv3 voltage-gated potassium channels regulate neurotransmitter release from mouse motor nerve terminalsAcquired neuromyotonia heralding recurrent thymoma in myasthenia gravis.A 48-year-old man with syncope and diffuse muscle twitches.Guidelines for treatment of autoimmune neuromuscular transmission disorders.Clinical features of limbic encephalitis with LGI1 antibody.Adult-onset drug-refractory seizure disorder associated with anti-voltage-gated potassium-channel antibodyCorticomotoneuronal function and hyperexcitability in acquired neuromyotonia.Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case seriesMorvan's syndrome: clinical, laboratory, and in vitro electrophysiological studies.Nerve excitability studies characterize Kv1.1 fast potassium channel dysfunction in patients with episodic ataxia type 1.An 11-year retrospective experience of antibodies against the voltage-gated potassium channel (VGKC) complex from a tertiary neurological centre.Management of paraneoplastic neurological syndromes: report of an EFNS Task Force.Bronchial involvement in the cramp-fasciculation syndrome.Clinical and immunological diversity of limbic encephalitis: a model for paraneoplastic neurologic disorders.Screening for tumours in paraneoplastic syndromes: report of an EFNS task force.Autoimmune causes of encephalitis syndrome in Thailand: prospective study of 103 patients.Autoimmune channelopathies of the nervous systemReactions of the immune system in epilepsyA Chinese female Morvan patient with LGI1 and CASPR2 antibodies: a case reportImmunology of disorders of neuromuscular transmission.Clinical aspects of neuromuscular transmission disorders.Autoimmune channelopathies.Voltage-gated potassium channelopathy: an expanding spectrum of clinical phenotypesMovement disorders in paraneoplastic and autoimmune disease.Nervous system KV7 disorders: breakdown of a subthreshold brake.Assessment of nerve excitability in toxic and metabolic neuropathies.Autoantibodies to glutamate receptors can damage the brain in epilepsy, systemic lupus erythematosus and encephalitis.Autoantibodies in neuromuscular transmission disorders.Opening paths to novel analgesics: the role of potassium channels in chronic painAutoantibodies in neuromuscular autoimmune disorders.Positive muscle phenomena--diagnosis, pathogenesis and associated disorders.Paraneoplastic immune-mediated neurological effects of systemic cancers.Paraneoplastic nerve hyperexcitability.Isaacs syndrome: A review.Adult-onset Satoyoshi syndrome and response to plasmapheresis.Axonal Excitability in Amyotrophic Lateral Sclerosis : Axonal Excitability in ALS.Eyelid myokymia in patients with migraine taking topiramate.
P2860
Q24595915-5820FCAA-0CEC-4EFD-BC43-33EE16089D96Q24799120-6362B3AE-637A-4AF0-AD0F-EDCBD949956EQ28244864-D5B0774D-A28C-4D3E-8FA1-940C82467808Q28508160-2D76ECD2-21A6-43D8-92D9-FE21904D8681Q30583597-C5AAF2D6-6E79-4E80-ABE0-94288A22C620Q33163199-197C6B93-7E33-4F48-AA68-7785527008A6Q33558942-F4E96FBC-C067-4058-BA40-D32E0F336234Q33825874-954E877B-37A3-444D-9DF4-519268840E0AQ34007635-ADC412C3-E235-4186-A402-5AFBFB79EB33Q34088650-7B596DD9-51E8-46C4-B91E-12F4BF922B8AQ34122865-B74987C0-0263-48BB-B28C-73D685905331Q34334990-5E9DFD21-6BC5-4BC7-AA3C-75FDA7F030B2Q34372981-37CABB80-AFC4-4C71-A09E-B95896DB2318Q34449781-8B99223E-EE7D-439D-8D4A-1A0EACC5C4D2Q34546579-4FF3BC53-8CC0-43AB-AC30-900D36E5FD2CQ34564617-9AF9E369-BC0F-4F02-B956-217DE1B82542Q34582727-994C6EA9-FA62-4A4A-8928-831F823026BDQ34911466-7AD8C5FF-2175-4E3D-A13A-8AAEE0AE2860Q35020678-66A05E31-490F-4C49-8227-3AB973E3FE23Q35151881-B90F5AA7-F09F-4603-944C-D011E49EFCA0Q35224998-B585D630-5019-4FF5-87D8-96802845DA71Q35960033-857DAE96-977C-458D-AC45-D8EC9AB231D9Q36459475-0B897A7C-21BE-402D-9C65-B7FADB0BE45AQ36459479-CB95607E-0589-4536-9916-7427579E07BAQ36577209-E5EE2A03-7A8D-450B-A3FC-5A195944A955Q36703242-B3AA28F6-4FF5-4B98-9B77-7CC9C288FF49Q36993609-620C7138-A3D2-4FE1-BD03-31D9A6D0FC6CQ37073177-116999A7-815D-407E-AF06-7267E4C4F04BQ37111987-104B6D2C-5CE4-4B1C-BA63-A1A7619F83EFQ37203376-2A0999E3-65CB-4CD1-A174-696E7161FD81Q37409082-50359146-C004-4F95-8BB4-47EC4E54E5A0Q37623462-F4002534-0F78-495F-927A-D9DA6049019CQ37754738-5EC078D8-04EC-4EDF-97BB-FD29D3C5CB89Q37978120-D084FA97-0562-44E2-B0C5-2C86E390B016Q38199135-EF0FF1FB-79D4-4360-832C-ED4A6681F863Q38319391-376D6EBA-82CE-405C-A594-6939CB77F8D2Q38367371-2A5B4861-4F8A-4AA6-825F-7DBE27ACF28AQ38839415-3A953D0C-FC89-4B5D-B852-93B888471920Q39017694-8466C433-5159-4A97-9769-81F54818CE70Q39023069-2FF32A78-ECE0-4B8B-A0DC-F35D9A204928
P2860
Phenotypic variants of autoimmune peripheral nerve hyperexcitability.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Phenotypic variants of autoimmune peripheral nerve hyperexcitability.
@ast
Phenotypic variants of autoimmune peripheral nerve hyperexcitability.
@en
type
label
Phenotypic variants of autoimmune peripheral nerve hyperexcitability.
@ast
Phenotypic variants of autoimmune peripheral nerve hyperexcitability.
@en
prefLabel
Phenotypic variants of autoimmune peripheral nerve hyperexcitability.
@ast
Phenotypic variants of autoimmune peripheral nerve hyperexcitability.
@en
P2093
P356
P1433
P1476
Phenotypic variants of autoimmune peripheral nerve hyperexcitability.
@en
P2093
Ian K Hart
John Newsom-Davis
Kerry R Mills
Paul Maddison
P304
P356
10.1093/BRAIN/AWF178
P407
P577
2002-08-01T00:00:00Z